Emergency percutaneous coronary dilatation for acute myocardial infarction in Behçet's disease

G Drobinski1, B Wechsler, A Pavie

  • 1Service de Cardiologie, C.H.U. Pittié-Salpétrière, Paris, France.

European Heart Journal
|October 1, 1987
PubMed

Insights

Behçet

Area of Science:

  • Cardiology
  • Rheumatology
  • Vascular Medicine

Background:

  • Behçet's disease is a rare multisystem inflammatory disorder.
  • Coronary artery involvement in Behçet's disease is uncommon but can be severe.
  • Acute coronary syndromes are a potential manifestation of Behçet's disease.

Observation:

  • A young male patient with Behçet's disease presented with acute coronary insufficiency.
  • Coronary arteriography identified two coronary aneurysms and significant stenosis in the left anterior descending (LAD) artery.
  • The patient experienced immediate relief of chest pain and ST segment changes after successful balloon angioplasty of the LAD stenosis.

Findings:

  • Successful percutaneous coronary intervention (PCI) for LAD stenosis led to favorable short-term outcomes, including limited myocardial infarction.
  • Surgical intervention was performed due to the risk of aneurysm rupture and hemopericardium.
  • Histopathological examination confirmed destructive arterial lesions characteristic of Behçet's disease, involving false aneurysms in the LAD and left circumflex arteries.

Implications:

  • This case highlights the importance of considering Behçet's disease in young patients presenting with acute coronary syndromes.
  • Percutaneous coronary intervention can be a viable option for managing acute coronary stenosis in Behçet's disease.
  • Aggressive management, including potential surgical intervention, is crucial for addressing complex coronary artery pathology in Behçet's disease to prevent life-threatening complications.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
344
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
592
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
525
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798